Floatz logo

14 assets in Heart Disorder

Therapeutic assets addressing Heart Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Acoramidis
Heart Disorder
Eidos Therapeutics, a BridgeBio companyP3BB (64)
Carvedilol
Heart Disorder
Abramson Cancer Center at Penn MedicineP3BB (64)
Aspirin
Heart Disorder
Assistance Publique - Hôpitaux de ParisP3B (60)
Colchicinum
Heart Disorder
Assistance Publique - Hôpitaux de ParisP3B (60)
Ticagrelor
Heart Disorder
Assistance Publique - Hôpitaux de ParisP3B (60)
Adriamycin
Heart Disorder
Beth Israel Deaconess Medical CenterP2CCC (53)
Dexrazoxane
Heart Disorder
Beth Israel Deaconess Medical CenterP2CCC (53)
Polatuzumab Vedotin
Heart Disorder
Beth Israel Deaconess Medical CenterP2CCC (53)
Rituximab
Heart Disorder
Beth Israel Deaconess Medical CenterP2CCC (53)
Sotagliflozin
Heart Disorder
Icahn School of Medicine at Mount SinaiP2CCC (53)
(+)-Vincristine
Heart Disorder
Beth Israel Deaconess Medical CenterP2CCC (53)
Silymarin
Heart Disorder
Tanta UniversityP2/3NR ()